Effects of melatonin in systemic lupus erythematosus
Not Applicable
- Conditions
- systemic lupus erythematosus.Systemic lupus erythematosus (SLE)
- Registration Number
- IRCT20110708006975N6
- Lead Sponsor
- Connective Tissue Diseases Research Center, Tabriz Unversity of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Having systemic lupus erythematosus according to ACR criteria and rheumatologist diagnosis
Eager to participate in study
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical symptoms. Timepoint: before and after intervention. Method of measurement: physician examination.;Disease activity. Timepoint: before and after intervention. Method of measurement: SLEDAI questionnaire.;Total antioxidant capacity. Timepoint: before and after intervention. Method of measurement: kit.;Malondialdehyde. Timepoint: before and after intervention. Method of measurement: florimetry.
- Secondary Outcome Measures
Name Time Method